Experienced in Primary Hyperoxaluria

Juan Peng

Guangdong Provincial Key Laboratory Of Marine Resources And Coastal Engineering, 
Zhuhai, CN 
Experienced in Primary Hyperoxaluria
Guangdong Provincial Key Laboratory Of Marine Resources And Coastal Engineering, 
Zhuhai, CN 
OverviewLocationsClinical Research

Overview

Juan Peng practices in Zhuhai, China. Mr. Peng is rated as an Experienced expert by MediFind in the treatment of Primary Hyperoxaluria. His top areas of expertise are Small Cell Lung Cancer (SCLC), Atherosclerosis, Pterygium, and Lung Cancer.

His clinical research consists of co-authoring 71 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Primary Hyperoxaluria.

Gender
Male

Locations

Guangdong Provincial Key Laboratory Of Marine Resources And Coastal Engineering, Zhuhai, 519082, China
Other Locations
Key Laboratory For Arteriosclerology Of Hunan Province, Hengyang, 421001, China
Shaoyang Branch Of Key Laboratory For Arteriosclerology Of Hunan Province, Shaoyang, 421001, China
Shenzhen, 518010, China
Key Laboratory Of Reproduction And Genetics Of Guangdong Higher Education Institutes, Key Laboratory For Major Obstetric Diseases Of Guangdong Province, P.R. China, Guangzhou, 510150, China
Key Laboratory For Arteriosclerology Of Hunan Province, Hengyang, 421001, China
Key Laboratory For Arteriosclerology Of Hunan Province, China
Nanfang, 510515, China
State Key Laboratory Of Catalysis, 457 Zhongshan Road, Zhongshan, 116023, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

71 Total Publications

PCSK9 Promotes Atherosclerotic Plaque Instability by Inducing VSMC Ferroptosis through the YAP1-NUPR1 Axis.
PCSK9 Promotes Atherosclerotic Plaque Instability by Inducing VSMC Ferroptosis through the YAP1-NUPR1 Axis.
Journal: Research (Washington, D.C.)
Published: July 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Peng's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile